Work

Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq Trial

Year: 2024

Type: dataset

DOI: 10.1200/jco.23.0309

Authors: Shannon Westin, Michael Atkins, Adil Daud, Gary Schwartz

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411175728

Cites:

Cited by:

Related to: 10